| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Arena Pharmaceuticals Inc (NASDAQ: ARNA)
ARNA Technical Analysis
5
| As on 14th Mar 2022 ARNA SHARE Price closed @ 99.99 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 69.63 & Strong Buy for SHORT-TERM with Stoploss of 74.68 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ARNASHARE Price
| Open | 99.99 | Change | Price | % |
| High | 99.99 | 1 Day | 0.00 | 0.00 |
| Low | 99.99 | 1 Week | 5.96 | 6.34 |
| Close | 99.99 | 1 Month | 8.75 | 9.59 |
| Volume | N/A | 1 Year | 25.01 | 33.36 |
| 52 Week High 99.99 | 52 Week Low 45.80 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| ARNA Daily Charts |
ARNA Intraday Charts |
Whats New @ Bazaartrend |
ARNA Free Analysis |
|
|
ARNA Important Levels Intraday
| RESISTANCE | 99.99 |
| RESISTANCE | 99.99 |
| RESISTANCE | 99.99 |
| RESISTANCE | 99.99 |
| RESISTANCE | 99.99 |
| RESISTANCE | 99.99 |
| RESISTANCE | 99.99 |
| RESISTANCE | 99.99 |
ARNA Forecast April 2024
| 4th UP Forecast | 152.25 |
| 3rd UP Forecast | 135.49 |
| 2nd UP Forecast | 125.13 |
| 1st UP Forecast | 114.77 |
| 1st DOWN Forecast | 85.21 |
| 2nd DOWN Forecast | 74.85 |
| 3rd DOWN Forecast | 64.49 |
| 4th DOWN Forecast | 47.73 |
ARNA Weekly Forecast
| 4th UP Forecast | 114.06 |
| 3rd UP Forecast | 109.55 |
| 2nd UP Forecast | 106.76 |
| 1st UP Forecast | 103.97 |
| 1st DOWN Forecast | 96.01 |
| 2nd DOWN Forecast | 93.22 |
| 3rd DOWN Forecast | 90.43 |
| 4th DOWN Forecast | 85.92 |
ARNA Forecast2024
| 4th UP Forecast | 205.01 |
| 3rd UP Forecast | 171.33 |
| 2nd UP Forecast | 150.51 |
| 1st UP Forecast | 129.69 |
| 1st DOWN Forecast | 70.29 |
| 2nd DOWN Forecast | 49.47 |
| 3rd DOWN Forecast | 28.65 |
| 4th DOWN Forecast | -5.03 |
Arena Pharmaceuticals Inc ( NASDAQ USA Symbol : ARNA )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ARNA Business Profile
Arena Pharmaceuticals, Inc., a biopharmaceutical company, focuses on providing novel medicines with pharmacology and pharmacokinetics to patients worldwide. Its investigational clinical programs include Etrasimod (APD334) that is in Phase III clinical trial for ulcerative colitis, Phase IIb/III clinical trial for Crohn's disease, Phase II clinical trial for alopecia areata, Phase III clinical trial for atopic dermatitis, and Phase IIb clinical trial for eosinophilic esophagitis; Olorinab (APD371), which is in Phase IIb clinical trial for the treatment of abdominal pain associated with irritable bowel syndrome; APD418 that is in Phase I clinical trial for acute heart failure; and Temanogrel for coronary microvascular obstruction is in Phase II clinical trial. It also develops ralinepag (APD811), which is in Phase III clinical trial for pulmonary arterial hypertension. The company has collaboration agreements with Second Genome, Inc.; United Therapeutics Corporation; Everest Medicines Limited; Beacon Discovery; Boehringer Ingelheim International GmbH; Eisai Co., Ltd.; Eisai Inc.; and Aristea Therapeutics, Inc. for the development of RIST4721 for treatment of serious immune-mediated inflammatory diseases. Arena Pharmaceuticals, Inc. was incorporated in 1997 and is based in Park City, Utah. Address: 136 Heber Avenue, Park City, UT, United States, 84060
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service